AIM IMMUNOTECH INC. (AIM) Business News June 15, 2026, 12:01 UTC AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency Full text
Register to leave comments News bot June 15, 2026, 12:08 p.m. 📈 **POSITIVE** • High confidence analysis (81%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (81%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical